Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
New to Comunitee?

or Sign Up with Email


>> AMGEN Latest News

JAN 28, 2015 - TheStreet

A Must Read - Share

Amgen (AMGN) Stock Declines Today Despite Earnings Beat

NEW YORK (TheStreet) -- Amgen shares are down 1.37% to $156.72 in trading on Wednesday following the release of the company's fourth quarter earnings after the closing bell yesteray. The world's largest biotech company reported a 27% increase in fourth quarter profits, earning net income of $1.3 billion, or $2.16 per share on an adjusted basis, as the company was helped by Congress ...

Tags: Amgen (AMGN) Stock Declines Today Despite Earnings Beat,  Amgen Latest News

JAN 28, 2015 - Zacks Investment Research

A Must Read - Share

JAN 28, 2015 - Benzinga

A Must Read - Share

Credit Suisse Sees Solid Q4 For Amgen

In a report published Wednesday, Credit Suisse analyst Ravi Mehrotra reiterated a Neutral rating and $180.00 price target on Amgen, Inc. (NASDAQ: AMGN). Latest Ratings for AMGN DateFirmActionFromTo Jan 2015BarclaysInitiates Coverage onEqual-weight Jan 2015Morgan StanleyDowngradesOverweightEqualweight Oct 2014CitigroupMaintainsBuy View More Analyst Ratings for AMGN View the Latest Analyst Ratings

Tags: Credit Suisse Sees Solid Q4 For Amgen,  Amgen Latest News

JAN 28, 2015 - Zero Hedge

A Must Read - Share

Frontrunning: January 28

Fed seen remaining patient with rate guidance amid global turmoil (Reuters) National Weather Service apologizes for blizzard forecast miss (CBS) Greek PM Tsipras pushes on with radical change, markets tumble (Reuters) Obama Drops Plan to Raise Taxes on ‘529’ College Savings Accounts (WSJ) Hard Choices on Easy Money Lie Ahead for Fed Chief (Hilsenrath) Debt That Once Boosted Its Cities ...

Tags: Frontrunning: January 28,  Amgen Latest News

JAN 28, 2015 - Yahoo! News

A Must Read - Share

Amgen profit tops expectations on Enbrel sales, tax credit

Despite pressure on overseas sales from the strong dollar that has put a crimp in pharmaceutical company profits, Amgen reiterated the 2015 forecast it provided in October for adjusted earnings of $9.05 to $9.40 per share on revenue of $20.8 billion to $21.3 billion. Amgen is less exposed to foreign exchange fluctuations than other large drugmakers as only about 25 ...

Tags: Amgen profit tops expectations on Enbrel sales, tax credit,  Amgen Latest News